FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/10/046813 [Registered on: 26/10/2022] Trial Registered Prospectively
Last Modified On: 24/10/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparative evaluation of microneedling with vitamin C and vitamin C alone in the management of thin gingival phenotype: A split mouth randomized clinical trial. 
Scientific Title of Study   Comparative evaluation of microneedling with vitamin C and vitamin C alone in the management of thin gingival phenotype: A split mouth randomized clinical trial. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Kulkarni Shruti Nitin 
Designation  PG student 
Affiliation  ACPM DENTAL COLLEGE 
Address  3 Department of Periodontics JMFs ACPM Dental College Dhule
3 Department of Periodontics JMFs ACPM Dental College Dhule
Dhule
MAHARASHTRA
424002
India 
Phone  8378077009  
Fax    
Email  snk1308@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anuradha Bhatsange 
Designation  Proffesor 
Affiliation  ACPM DENTAL COLLEGE 
Address  3 Department of Periodontics JMFs ACPM Dental College Dhule
3 Department of Periodontics JMFs ACPM Dental College Dhule
Dhule
MAHARASHTRA
424002
India 
Phone  8378077009  
Fax    
Email  anujaps219@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Kulkarni Shruti Nitin 
Designation  PG student 
Affiliation  ACPM DENTAL COLLEGE 
Address  3 Department of Periodontics JMFs ACPM Dental College Dhule
3 Department of Periodontics JMFs ACPM Dental College Dhule
Dhule
MAHARASHTRA
424002
India 
Phone  8378077009  
Fax    
Email  snk1308@gmail.com  
 
Source of Monetary or Material Support  
ACPM Dental college, sakri road Dhule 
 
Primary Sponsor  
Name  Kulkarni Shruti Nitin 
Address  3 Department of Periodontics JMFs ACPM Dental College Dhule 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Kulkarni Shruti Nitin  ACPM DENTAL COLLEGE  3 Department of Periodontics JMFs ACPM Dental College Dhule
Dhule
MAHARASHTRA 
8378077009

snk1308@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ACPM DENTAL COLLEGE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  thin gingival phenotype (GT≤1mm) in maxillary and/or mandibular anterior region  
Patients  (1) ICD-10 Condition: K05||Gingivitis and periodontal diseases,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group 1: MICRONEEDLING AND VITAMIN C INJECTION  First microneedling will be performed using dermapen and then injectable form of vitamin C (100mg) will be injected with the help of insulin syringe. A total of 4 sessions will be done with the interval of 1 week each. And all the parameters will be measured 
Comparator Agent  Group 2: VITAMIN C INJECTION  Injectable form of vitamin C (100mg) will be injected with the help of insulin syringe. A total of 4 sessions will be done with the interval of 1 week each. And all the parameters will be measured 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1. Age ≥18 years diagnosed with thin gingival phenotype
(≤1mm) in maxillary and/or mandibular anterior region.
2. Patients willing to participate in the study
 
 
ExclusionCriteria 
Details  1. Systemically compromised patients
2. Heavy smokers (>10 cigarettes per day)
3. Pregnant or lactating women
4. Patients who have been previously undergone periodontal therapy
5. Patients with active orthodontic treatment
6. Aggressive or chronic periodontitis

 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
Gingival thickness (GT)
GT will be determined at a mid-buccal location about 1mm apical to the Pocket Depth with a #15 K file.
And keratinized tissue width
 
3 months 
 
Secondary Outcome  
Outcome  TimePoints 
Probing depth (PD)
Clinical attachment level (CAL)
 
3 months 
 
Target Sample Size   Total Sample Size="25"
Sample Size from India="25" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   31/10/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="11"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Title: Comparative evaluation of microneedling with vitamin C and vitamin C alone in the management of thin gingival phenotype: A split mouth randomized clinical trial.
introduction: The periodontium is formed by supporting tissues which invest the tooth i.e., the root cementum, periodontal ligament, bone lining the tooth socket (alveolar bone) and the part of gingiva facing the tooth. [1] The gingiva is the part of the oral mucosa that covers the alveolar processes of the jaws and surrounds the necks of the teeth. [2]

 Variation in gingival and osseous architecture have shown significant impact on treatment outcomes. Hence gingival phenotype has to be evaluated. Ochsenbein and Ross in 1969 suggested 2 main types of gingival anatomy, flat and highly scalloped. [3] Later on, in 1989 Seibert and Lindhe proposed the term ‘Gingival Biotype’ and defined it as the thickness of gingiva in facio-palatal direction, which was classified as thick flat and thin scalloped. [3] A gingival thickness of ≥ 2mm is considered as thick tissue biotype and <1.5 mm is referred as thin tissue biotype. [4] In 2017, the World Workshop of Periodontics advocated the term ‘phenotype’ instead of biotype.[4] Phenotype refers to the collection of traits or characteristics, it is determined by the interaction of genes and the environment.[2] Gingival phenotype is a combination of gingival thickness (GT) and the keratinised tissue width (KTW) whereas, periodontal phenotype is referred as the combination of gingival phenotype and bone morphotype (buccal bone thickness). [5]

  A thin gingival phenotype, in addition to a lack of KTW, is more prone to gingival recession.[5] Thick tissue phenotype has been associated with better outcomes following corrective periodontal procedures, such as root coverage with coronally advanced flap. Gingival phenotype has a significant impact on the outcome of the restorative, regenerative and implant therapy. [4]

   Various surgical and non-surgical methods have been employed to increase gingival thickness that includes pedicle flap, soft tissue grafts and xenogeneic collagen matrix.[6] However, recent advancements in management of thin gingival phenotype include the use of novel non-invasive materials like i-PRF and hyaluronic acid.[5]

    The concept of microneedling (MN), a minimally invasive technique was developed in 1994 and since 1995 it has been practiced in cosmetic dermatology.[7] Microneedling refers to a non-surgical procedure also known as ‘percutaneous collagen induction therapy’. [7] It was first used in dentistry by Zeliha Betul Ozsagir and co-authors. MN induces microinjuries resulting in minimal superficial bleedings along with creation of wound- healing cascade releasing various growth factors like platelet-derived growth factors, transforming growth factors, connective tissue growth factor and fibroblast growth factors. Thus, the tissue responds to these microinjuries leading to increased body’s own collagen production. Fibroblasts produce collagen and elastin fibres by migrating to the point of intrusion for wound closure. Newly formed fibres thicken the tissue during a process known as neocollagenesis. Fibroblasts also trigger neoangiogenesis by stimulating the proliferation of endothelial cells in the vessels. [8]
 Vitamin C, a water-soluble vitamin with abundant antioxidant property, is a cofactor for two enzymes, lysyl and prolyl hydroxylases, responsible for collagen hydroxylation. Its vital role in biosynthesis, function of collagen, and extracellular matrix along with promotion of gene expression of fibroblasts have shown a great potential in regenerative medicine. Due to lack of enzyme L-gluconolactone it cannot be synthesized in humans. Apart from dietary supplements Vitamin C is available as oral tablets, chewable tablets, creams, serum, transdermal patches and injectable form of vitamin C. In the present study injectable form of vitamin C (100mg) will be used with the help of insulin syringe,[11] and microneedling will be performed using dermapen.[12]

 Thereby, the study aims at comparative evaluation of microneedling with vitamin C and vitamin C alone in the management of thin gingival phenotype.

Study design: Randomized clinical trial (split mouth study)

 

Study setting:

The study will be conducted in clinical setting in Department of Periodontology.

Study population: The study will include 25 patients diagnosed with thin gingival phenotype and categorized into two groups,

Group 1: microneedling + vitamin C injection

Group 2: vitamin C injection alone

 

Sample size estimation:

Sample size was estimated by using the data obtained from previous study conducted by Gupta S et. al. (Journal of Clinical Periodontology. 2020 Nov, 47(4): 489-499).

This calculator uses the following formulas to compute sample size:

        (σ12+ σ22) (Z1-α/2 + Z1-β)2

n = ---------------------------------

                    (μA – μB)2

where,

σ1 is standard deviation of 1st group (pre) = 0.05

σ2 is standard deviation of 2nd group (post) = 0.05

μA is mean of 1st Group (Pre) = 0.17 

μB is mean of 2nd Group (Post) = 0.13

α is Type I error = 0.05

β is Type II error = 0.20 i.e., 1 – β is power = 80%

Z1-α/2 = two-sided Z value (eg. Z=1.96 for 95% confidence interval).

Z1-β = 0.84 for 80% power

Substituting these values in above-mentioned formula, the sample size estimated was n = 25 samples.

 

Methods of selection:

Inclusion criteria:

1.     Age ≥18 years diagnosed with thin gingival phenotype

(≤1mm) [5] in maxillary and/or mandibular anterior region.

2.     Patients willing to participate in the study

 

Exclusion criteria:[8]

1.     Systemically compromised patients

2.     Heavy smokers (>10 cigarettes per day)

3.     Pregnant or lactating women

4.     Patients who have been previously undergone periodontal therapy

5.     Patients with active orthodontic treatment

6.     Aggressive or chronic periodontitis

 

 

Materials required

1.     Mouth mirror, explorer

2.     University of North Carolina number 15 probe (UNC15)

3.     Digital vernier calliper

4.     Topical local anaesthetic agent

5.     Endodontic K file 15 number [5]

6.     Injectable vitamin C

7.     Sterile Gauze

8.     Normal saline for irrigation

9.     Five ml syringe and needle

10.  Insulin syringe with Needle

11.  Dermapen with cartridge [12]

 

 

Clinical parameters:[8]

1)     Gingival thickness (GT)

2)     Keratinised tissue width (KTW)

3)     Plaque index (PI)

4)     Gingival index (GI)

5)     Bleeding on probing (BOP)

6)     Probing depth (PD)

7)     Clinical attachment level (CAL)

 

 

 

Method: [8,11,12,21]

First visit:

After obtaining informed written consent and detailed case history from the patient, all the participants will undergo phase-I therapy.  In this split mouth study, 25 patients with thin gingival phenotype in the maxillary and/or mandibular anterior region will be selected and randomly allocated to one of the two groups by flip coin technique.  MN+vitamin C injection will be performed on one side and vitamin C injection will be administered on the other side. In MN+vitamin C group, microneedling will be performed using microneedling device (dermapen) to induce bleeding and after thorough irrigation with normal saline, a saline soaked gauze will be placed between the gingiva and lip to control bleeding. Then 1ml vitamin C (100mg) will be injected with the help of 30G insulin needle 2-3mm apical to the gingival margin, on the both sides.

Same procedure will be repeated for next three visits with the interval of 1 week.

Follow up:

The following parameters will be assessed at one month and three months from the baseline: Gingival Thickness, Keratinised Tissue Width, Plaque Index, Gingival Index, Bleeding on Probing, Probing Depth, Clinical Attachment Level.

 

Statistical analysis:

Statistical analysis will be carried using SPSS software v26. Level of significance will be kept at 5%.

Data will be subjected to normality testing using Shapiro wilk test.

Depending on the results of normality testing, intragroup comparison of change in each variable within each group between different time intervals will be performed using either repeated measure ANOVA test or Friedman test.

Intergroup comparison of each variable, comparison of each variable between two groups will be performed using independent t test or Mann Whitney test.


 
Close